Novostia Obtains EUR 2.5 Million Grant from the European Union To Support Its Heart Valve Technology
Novostia announces that it has been awarded EUR 2.5 million grant from the European Union under the highly competitive Horizon 2020 EIC Accelerator.
The EIC Accelerator is part of the European Innovation Council (EIC) pilot that supports topclass companies with funding opportunities and acceleration services to help them develop and bring to market innovative products that have high potential to drive economic growth.
Novostia aims at improving the quality of life of people suffering from heart valve disease, especially children and young patients, providing them with a unique, durable, anticoagulant-free and silent heart valve prosthesis.
“This grant, together with our recent financing round of CHF 6.5 million, will accelerate the development of our technology toward the first in human studies. We appreciate the trust and support from the European Union, our investors, and partners and look forward to bringing this long-awaited innovation to patients and physicians” , said Geoffroy Lapeyre, Novostia CEO.
Novostia is a privately held medical device company incorporated in 2017 in Microcity Neuchâtel, Switzerland, developing an innovative artificial heart valve. For more information, please visit www.novostia.com
Caution: Novostia technology is an investigational device not yet approved for sale.
About Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
SAMSUNG-ELECTRONICS13.8.2020 08:18:11 CEST | Press release
Samsung Announces Availability of its Silicon-Proven 3D IC Technology for High-Performance Applications
LENOVO13.8.2020 06:48:10 CEST | Press release
Lenovo Delivers Outstanding Q1 Performance and Strong Growth, Overcoming Challenging Global Environment
WORLDREMIT13.8.2020 03:13:14 CEST | Press release
Win a Tablet with WorldRemit’s Back to School Competition!
OR-LATTICE-SEMICONDUCTOR12.8.2020 22:02:08 CEST | Press release
Lattice Sentry Solutions Stack and SupplyGuard Service Deliver End-to-End Supply Chain Protection with Dynamic Trust
CA-ANDERSEN-GLOBAL12.8.2020 15:56:09 CEST | Pressemeddelelse
Andersen Global styrker platformen i Afrika med tilføjelsen af et advokatfirma i Gabon
BOEHRINGER-INGELHEIM12.8.2020 14:38:12 CEST | Press release
Phase III InPedILD™ trial enrolls first patient to evaluate nintedanib in pediatric population with fibrosing interstitial lung disease
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom